Sally Hines believes pregnant trans-identified women should take testosterone despite the risk to the baby because society places too much emphasis on 'normative outcomes' #TransRights #ReproductiveHealth #GenderIdentity #Thetweetdoesnotmentionanyspecificcountries.Therefore #therearenocountrycodestoreturn.
RT @JezziiB: 99 years is the amount of prison time a doctor in Alabama will receive if they perform an abortion. 6 months is the amount of… #AbortionRights #ReproductiveHealth #JusticeForWomen #US
Abortion pills, particularly mifepristone, have become the predominant method of terminating pregnancies in the US, especially in states like Louisiana where abortion is banned, leading to legal battles over mail distribution and state laws, culminating in a recent Supreme Court ruling that temporarily reinstates in-person requirements for obtaining the pills. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
In the U.S., abortion pills are increasingly used for terminating pregnancies, especially in states with bans, but a recent ruling by an appeals court reinstated a requirement for in-person acquisition of these pills, leading manufacturers to seek intervention from the Supreme Court amidst a legal battle initiated by Louisiana to uphold its abortion restrictions. #AbortionRights #ReproductiveHealth #Telemedicine #US #LA
Abortion pills have become the most prevalent method for terminating pregnancies in the US, particularly in states with abortion bans, leading to a legal dispute in Louisiana where the FDA's allowance for remote access to these pills prompted a lawsuit attempting to reinstate in-person requirements, which has been temporarily upheld by an appeals court while the Supreme Court considers a case from the drug manufacturers. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
In the ongoing legal battles over abortion access in the United States, particularly in Louisiana, the Supreme Court has temporarily reinstated a requirement for in-person procurement of abortion pills, countering a recent FDA policy that allowed for mail delivery of mifepristone, following a lawsuit claiming this delivery method undermines state abortion bans. #AbortionRights #ReproductiveHealth #Telemedicine #US #LA
In a legal battle over abortion pill accessibility in the U.S., the Supreme Court temporarily reinstated a requirement for in-person acquisition of mifepristone, countering the FDA's recent allowance for mail delivery, amidst Louisiana's lawsuit challenging the federal action and its conflict with the state's abortion ban. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
Abortion pills, primarily mifepristone, have become the leading method for terminating pregnancies in the U.S., particularly in states with abortion bans, prompting legal challenges like Louisiana's lawsuit against the FDA to halt mail delivery of the pills; an appeals court recently reinstated an in-person requirement for obtaining them, while the Supreme Court faces a case from mifepristone manufacturers regarding the legality of these restrictions. #AbortionRights #ReproductiveHealth #Telemedicine #US #LA
In the U.S., abortion pills have become the most common method for terminating pregnancies, particularly in states with abortion bans, prompting Louisiana to sue the FDA over mail distribution of mifepristone, leading to a temporarily reinstated in-person requirement by an appeals court and a subsequent stay from the Supreme Court as drug manufacturers seek to challenge the ruling. #AbortionRights #ReproductiveHealth #Telemedicine #US #LA
In her article, Molly Jong-Fast discusses the imminent Supreme Court decision regarding the abortion drug mifepristone, outlining three potential outcomes that could either restrict access to abortion pills or maintain their availability, while emphasizing that making abortions illegal does not eliminate them; it only makes them less safe. #AbortionRights #ReproductiveHealth #SCOTUS #US #LA
The article discusses the impending Supreme Court decision on the abortion drug mifepristone, explaining that making abortion pills illegal does not stop abortions but rather increases the danger by forcing women to seek unsafe alternatives, highlighting three potential rulings the court might make that could significantly impact access to abortion and women's health care. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
The article discusses the impending Supreme Court decision on the abortion drug mifepristone and explores three possible outcomes, highlighting the implications of restricting access to abortion pills, which could lead to unsafe abortions and exacerbate existing disparities in reproductive healthcare. #AbortionRights #ReproductiveHealth #SupremeCourtDecision #US #LA
The article discusses the implications of the Supreme Court's impending decision on the abortion drug mifepristone, highlighting that making abortion illegal does not stop the procedure but rather makes it unsafe, and presenting three potential outcomes that could significantly impact access to abortion pills and reproductive rights in the U.S. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
The article discusses the Supreme Court's impending decision on the abortion drug mifepristone amidst growing political and social tensions surrounding abortion rights, highlighting three potential outcomes that could significantly affect women's access to safe abortions and the implications of restricting such medications. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
The article discusses the impending Supreme Court decision on the abortion drug mifepristone amidst increasing political focus on abortion rights, highlighting three potential outcomes that could adversely impact access to safe abortions and reproductive healthcare in the U.S., and emphasizing that making abortions illegal does not eliminate the practice, but rather endangers women's lives. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
The article discusses the impending Supreme Court decision on the abortion drug mifepristone, noting that banning the medication would not stop abortions but would instead make them unsafe, while outlining three possible outcomes of the Court's ruling, which could significantly impact women’s access to reproductive healthcare. #AbortionRights #SupremeCourt #ReproductiveHealth #US #LA
The article discusses the Supreme Court's impending decision on the abortion drug mifepristone, highlighting the potential outcomes which could either maintain access, impose in-person requirements for obtaining it, or make the drug illegal altogether, emphasizing that restricting abortion availability does not stop the procedure but rather endangers women's health by increasing unsafe alternatives. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
The article discusses the implications of the Supreme Court's upcoming decision on the abortion drug mifepristone, outlining three potential outcomes that could either restrict access to the drug or maintain its availability, while highlighting the dangers of making abortions illegal, which historically leads to unsafe practices. #AbortionRights #ReproductiveHealth #SupremeCourtDecision #US #LA
The article discusses the upcoming Supreme Court decision on the abortion drug mifepristone, outlining three potential outcomes that could significantly impact access to abortion: upholding the current ability to receive the drug by mail, reinstating in-person requirements for obtaining it, or outright banning it, with the latter option raising concerns about women's safety and autonomy reminiscent of pre-1973 abortion conditions. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
In an examination of the Supreme Court's impending decision on the abortion drug mifepristone, Molly Jong-Fast emphasizes that making abortions illegal does not stop them; it only endangers women's health by limiting access to safe procedures, and discusses three potential rulings the Court may make, each with significant implications for reproductive rights and healthcare access in the U.S. #AbortionRights #ReproductiveHealth #SupremeCourt #US #LA
